Volpara and ScreenPoint Medical Sign Memorandum of Understanding (MOU)
Volpara and image analysis developer ScreenPoint Medical have signed an MOU which will see the two companies seek to bring ScreenPoint’s artificial intelligence–based Transpara detection and decision support software to...
VHT FY2018 Results Summary
In this interview, Dr Ralph Highnam, CEO provides insight into the FY2018 results and outlines the Company’s goals for FY2019.
Customer Success is Transformative—Our Transition to SaaS
When Volpara Health Technologies first commenced operations, we were a traditional medical device company—we built software products, sold them and then went back to the purchaser when we had something...
Introducing Dr Monica Saini, Volpara’s Consultant Diagnostic Radiologist
Cancer is the ultimate egalitarian, anyone is susceptible. This makes it the most fascinating of subjects.
VHT Year in Review
In this interview, Dr Ralph Highnam, CEO provides his perspective on the year that was, including updates on progress and sets out targets for the year ahead.
VHT 2017 Full Year Financial Results and Sales Update
Volpara CEO Ralph Highnam discusses the 2017 Full Year Financial Results and gives a sales update.
Ralph Highnam—From Math Grad to CEO
You may think a degree in math or physics is reserved for more bookish types that aim for career paths in labs, academia, or sci-fi-esque pursuits.
